Latest article
Section III Trial Reveals Lilly’s Tirzepatide is Superior to Rival in Kind 2 Diabetes
Jonathan Weiss / Shutterstock
Eli Lillys The Phase III SURPASS 2 clinical trial shows treatment with tirzepatide, a once-weekly dual glucose-dependent insulinotropic polypeptide and glucagon-like...
Coronavirus pandemic fueled new health tendencies, analysis exhibits – WISH-TV | Indianapolis Information |...
INDIANAPOLIS (WISH) — The...